BDSX

Biodesix, Inc. Common Stock

29.77

USD

+0.48

+1.65%

Sep 24, 10:25 UTC -4

Open

BDSX Earnings Reports

Positive Surprise Ratio

BDSX beat 16 of 24 last estimates.

67%

Next Report

Date of Next Report

Nov 02, 2026

Estimate for Q3 26 (Revenue/ EPS)

$28.11M

-$0.76

Implied change from Q2 26 (Revenue/ EPS)

+4.64%

+7.04%

Implied change from Q3 25 (Revenue/ EPS)

+29.13%

-33.91%

Biodesix, Inc. Common Stock earnings per share and revenue

On Aug 05, 2026, BDSX reported earnings of -0.71 USD per share (EPS) for Q2 26, beating the estimate of -0.92 USD, resulting in a 22.85% surprise. Revenue reached 26.86 million, compared to an expected 26.55 million, with a 1.19% difference. The market reacted with a -2.99% price change (close before vs. close after earnings).

Looking ahead to Q3 26, 5 analysts forecast an EPS of -0.76 USD, with revenue projected to reach 28.11 million USD, implying an increase of 7.04% EPS, and increase of 4.64% in Revenue from the last quarter.

FAQ

What were Biodesix, Inc. Common Stock's earnings and revenue for the latest quarter Q2 2026?

For Q2 2026, Biodesix, Inc. Common Stock reported EPS of -$0.71, beating estimates by 22.85%, and revenue of $26.86M, 1.19% above expectations.

How did the market react to Biodesix, Inc. Common Stock's Q2 2026 earnings?

The stock price moved down -2.99%, changed from $22.78 before the earnings release to $22.10 the day after.

When is Biodesix, Inc. Common Stock expected to report next?

The next earning report is scheduled for Nov 02, 2026.

What are the forecasts for Biodesix, Inc. Common Stock's next earnings report?

Based on 5 analysts, Biodesix, Inc. Common Stock is expected to report EPS of -$0.76 and revenue of $28.11M for Q3 2026.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.